Mephedrone (4-methylmethcathinone), a principal constituent of psychoactive bath salts, produces behavioral sensitization in rats

Drug and Alcohol Dependence

Volumn 133, Issue 2, 2013, Pages 746-750

  Gregg, Ryan A ^a   Tallarida, Christopher S ^a   Reitz, Allen ^b   McCurdy, Christopher ^c   Rawls, Scott M ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Fox Chase Chemical Diversity Center   (United States)

^c UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Bath salts; Behavioral sensitization; Cathinone; MEPH; Mephedrone; Stereotypy

Indexed keywords

4' METHYLMETHCATHINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPULSION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG DOSE REGIMEN; DRUG EXPOSURE; DRUG WITHDRAWAL; EXPERIMENTAL STUDY; LOCOMOTION; LOW DRUG DOSE; MALE; MOBILIZATION; MOTOR DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION;

RATTUS;

BATH SALTS; BEHAVIORAL SENSITIZATION; CATHINONE; MEPH; MEPHEDRONE; STEREOTYPY;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; METHAMPHETAMINE; MOVEMENT; RATS; RATS, SPRAGUE-DAWLEY; STEREOTYPED BEHAVIOR;

EID: 84887016522     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.06.014     Document Type: Article

References (18)

1. Ball K.T., Budreau D., Rebec G.V. Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats. Eur. J. Neurosci. 2006, 24:217-228.
2. Ball K.T., Klein J.E., Plocinski J.A., Slack R. Behavioral sensitization to 3,4-methylenedioxymethamphetamine is long-lasting and modulated by the context of drug administration. Behav. Pharmacol. 2011, 22:847-850.
3. Baumann M.H., Ayestas M.A., Partilla J.S., Sink J.R., Shulgin A.T., Daley P.F., Brandt S.D., Rothman R.B., Ruoho A.E., Cozzi N.V. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 2012, 37:1192-1203.
4. Baumann M.H., Partilla J.S., Lehner K.R. Psychoactive "bath salts": not so soothing. Eur. J. Pharmacol. 2013, 698:1-5.
5. Cameron K., Kolanos R., Verkariya R., De Felice L., Glennon R.A. Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter. Psychopharmacology (Berl.) 2013, 227:493-499.
6. Hadlock G.C., Webb K.M., McFadden L.M., Chu P.W., Ellis J.D., Allen S.C., Andrenyak D.M., Vieira-Brock P.L., German C.L., Conrad K.M., Hoonakker A.J., Gibb J.W., Wilkins D.G., Hanson G.R., Fleckenstein A.E. 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. J. Pharmacol. Exp. Ther. 2011, 339:530-536.
7. Huang P.K., Aarde S.M., Angrish D., Houseknecht K.L., Dickerson T.J., Taffe M.A. Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats. Drug Alcohol Depend. 2012, 126:168-175.
8. Kalivas P.W., Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J. Neurosci. 1993, 13:266-275.
9. Kalivas P.W., Duffy P., White S.R. MDMA elicits behavioral and neurochemical sensitization in rats. Neuropsychopharmacology 1998, 18:469-479.
10. Kehr J., Ichinose F., Yoshitake S., Goiny M., Sievertsson T., Nyberg F., Yoshitake T. Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats. Br. J. Pharmacol. 2011, 164:1949-1958.
11. Lisek R., Xu W., Yuvasheva E., Chiu Y.T., Reitz A.B., Liu-Chen L.Y., Rawls S.M. Mephedrone ('bath salt') elicits conditioned place preference and dopamine-sensitive motor activation. Drug Alcohol Depend. 2012, 126:257-262.
12. Motbey C.P., Hunt G.E., Bowen M.T., Artiss S., McGregor I.S. Mephedrone (4-methylmethcathinone, 'meow'): acute behavioural effects and distribution of Fos expression in adolescent rats. Addict. Biol. 2012, 17:409-422.
13. Paulson P.E., Camp D.M., Robinson T.E. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacol. (Berl.) 1991, 103:480-492.
14. Rasmussen B., Unterwald E.M., Rawls S.M. Glutamate transporter subtype 1 (GLT-1) activator ceftriaxone attenuates amphetamine-induced hyperactivity and behavioral sensitization in rats. Drug Alcohol Depend. 2011, 118:484-488.
15. Robinson T.E., Camp D.M. Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion. Pharmacol. Biochem. Behav. 1987, 26:821-827.
16. Shortall S.E., Macerola A.E., Swaby R.T., Jayson R., Korsah C., Pillidge K.E., Wigmore P.M., Ebling F.J., Richard Green A., Fone K.C., King M.V. Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat. Eur. Neuropsychopharmacol. 2012, (Epub ahead of print).
17. Steketee J.D., Kalivas P.W. Drug wanting: behavioral sensitization and relapse to drug-seeking behavior. Pharmacol. Rev. 2011, 63:348-365.
18. Winstock A., Mitcheson L., Ramsey J., Davies S., Puchnarewicz M., Marsden J. Mephedrone: use, subjective effects and health risks. Addiction 2011, 106:1991-1996.